Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Microsatellite instability in Japanese female patients with triple-negative breast cancer.

Kurata K, Kubo M, Kai M, Mori H, Kawaji H, Kaneshiro K, Yamada M, Nishimura R, Osako T, Arima N, Okido M, Oda Y, Nakamura M.

Breast Cancer. 2020 Jan 6. doi: 10.1007/s12282-019-01043-5. [Epub ahead of print]

PMID:
31907878
2.

Huge abdominal cerebrospinal fluid pseudocyst following ventriculoperitoneal shunt: a case report.

Koide Y, Osako T, Kameda M, Ihoriya H, Yamamoto H, Fujisaki N, Aokage T, Yumoto T, Date I, Naito H, Nakao A.

J Med Case Rep. 2019 Dec 10;13(1):361. doi: 10.1186/s13256-019-2308-0.

3.

Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature.

Luangxay T, Osako T, Yonekura R, Sugiura Y, Kikuchi M, Gomi N, Ueno T, Ohno S, Machinami R, Takeuchi K, Akiyama F.

Pathol Res Pract. 2019 Nov 19:152750. doi: 10.1016/j.prp.2019.152750. [Epub ahead of print]

PMID:
31784095
4.

Management of retropharyngeal lymph node metastasis in oral cancer.

Oikawa Y, Michi Y, Tsushima F, Tomioka H, Mochizuki Y, Kugimoto T, Osako T, Nojima H, Yokokawa M, Kashima Y, Harada H.

Oral Oncol. 2019 Dec;99:104471. doi: 10.1016/j.oraloncology.2019.104471. Epub 2019 Nov 1.

PMID:
31678766
5.

Orbital Emphysema as a Consequence of Forceful Nose-Blowing: Report of a Case.

Ariyoshi Y, Naito H, Yumoto T, Iida A, Yamamoto H, Fujisaki N, Aokage T, Tsukahara K, Yamada T, Mandai Y, Osako T, Nakao A.

Case Rep Emerg Med. 2019 Jun 18;2019:4383086. doi: 10.1155/2019/4383086. eCollection 2019.

6.

Case of Nontraumatic Rectus Sheath Hematoma from Muscle Training Mimicking Acute Abdomen.

Ariyoshi Y, Naito H, Ihoriya H, Yumoto T, Fujisaki N, Tsukahara K, Yamada T, Mandai Y, Osako T, Nakao A.

Case Rep Emerg Med. 2019 May 23;2019:3158969. doi: 10.1155/2019/3158969. eCollection 2019.

7.

Emphysematous cystitis successfully treated with hyperbaric oxygen therapy: case report.

Yasuhara H, Naito H, Kosaki Y, Yamakawa Y, Iida A, Yumoto T, Yamamoto H, Yamada T, Tsukahara K, Osako T, Mandai Y, Nakao A.

Undersea Hyperb Med. 2018 Nov-Dec;45(6):701-703.

PMID:
31158940
8.

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.

Mori H, Kubo M, Kai M, Yamada M, Kurata K, Kawaji H, Kaneshiro K, Osako T, Nishimura R, Arima N, Okido M, Kishimoto J, Oda Y, Nakamura M.

Breast Cancer Res Treat. 2019 Aug;176(3):569-577. doi: 10.1007/s10549-019-05256-2. Epub 2019 May 8.

9.

Gastric Emphysema in a Critically Ill Patient Successfully Treated without Surgery.

Ihoriya H, Yumoto T, Iwamuro M, Fujisaki N, Osako T, Naito H, Nakao A.

Case Rep Crit Care. 2019 Mar 18;2019:1824101. doi: 10.1155/2019/1824101. eCollection 2019.

10.

Increase in the incidence of dermatitis after flood disaster in Kurashiki area possibly due to calcium hydroxide.

Yamada T, Osako T, Iida A, Yumoto T, Tsukahara K, Watanabe A, Naito H, Nakao A.

Acute Med Surg. 2019 Jan 10;6(2):208-209. doi: 10.1002/ams2.389. eCollection 2019 Apr. No abstract available.

11.

A patient presenting painful chest wall swelling: Tietze syndrome.

Sawada K, Ihoriya H, Yamada T, Yumoto T, Tsukahara K, Osako T, Naito H, Nakao A.

World J Emerg Med. 2019;10(2):122-124. doi: 10.5847/wjem.j.1920-8642.2019.02.011. No abstract available.

12.

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.

Miyoshi Y, Shien T, Ogiya A, Ishida N, Yamazaki K, Horii R, Horimoto Y, Masuda N, Yasojima H, Inao T, Osako T, Takahashi M, Tomioka N, Wanifuchi-Endo Y, Hosoda M, Doihara H, Yamashita H.

Oncol Lett. 2019 Feb;17(2):2177-2186. doi: 10.3892/ol.2018.9853. Epub 2018 Dec 19.

13.

Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors.

Arima N, Nishimura R, Osako T, Okumura Y, Nakano M, Fujisue M, Nishiyama Y, Toyozumi Y.

Oncol Lett. 2019 Jan;17(1):616-622. doi: 10.3892/ol.2018.9633. Epub 2018 Oct 29.

14.

Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery.

Shoji Y, Kumagai K, Kamiya S, Ida S, Nunobe S, Ohashi M, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Osako T, Yamamoto N, Fujisaki J, Sano T, Hiki N.

Gastric Cancer. 2019 Jul;22(4):873-880. doi: 10.1007/s10120-018-00919-3. Epub 2019 Jan 3.

PMID:
30603913
15.

Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast.

Yonekura R, Osako T, Iwase T, Ogiya A, Ueno T, Kitagawa M, Ohno S, Akiyama F.

Breast Cancer Res Treat. 2019 Feb;174(1):103-111. doi: 10.1007/s10549-018-5068-4. Epub 2018 Nov 24.

PMID:
30474777
16.

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.

Johmura Y, Maeda I, Suzuki N, Wu W, Goda A, Morita M, Yamaguchi K, Yamamoto M, Nagasawa S, Kojima Y, Tsugawa K, Inoue N, Miyoshi Y, Osako T, Akiyama F, Maruyama R, Inoue JI, Furukawa Y, Ohta T, Nakanishi M.

J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12.

17.

Usefulness of 3-D computed tomography for diagnosis of abusive head trauma.

Zensho K, Yamamoto H, Tsukahara K, Osako T, Nakao A.

Pediatr Int. 2018 Sep;60(9):889-891. doi: 10.1111/ped.13633. Epub 2018 Sep 5. No abstract available.

PMID:
30187595
18.

Ictal Cardiorespiratory Arrest Associated with Status Epilepticus in Panayiotopoulos Syndrome.

Yamamoto H, Naito H, Osako T, Tsukahara K, Yamada T, Yumoto T, Iida A, Kosaki Y, Oka M, Endo F, Gochi A, Nakao A.

Acta Med Okayama. 2018 Jun;72(3):297-300. doi: 10.18926/AMO/56076.

19.

Aqueous Asymmetric 1,4-Addition of Arylboronic Acids to Enones Catalyzed by an Amphiphilic Resin-Supported Chiral Diene Rhodium Complex under Batch and Continuous-Flow Conditions.

Shen G, Osako T, Nagaosa M, Uozumi Y.

J Org Chem. 2018 Jul 20;83(14):7380-7387. doi: 10.1021/acs.joc.8b00178. Epub 2018 Mar 30.

PMID:
29565135
20.

Cushing's sign and severe traumatic brain injury in children after blunt trauma: a nationwide retrospective cohort study in Japan.

Yumoto T, Naito H, Yorifuji T, Maeyama H, Kosaki Y, Yamamoto H, Tsukahara K, Osako T, Nakao A.

BMJ Open. 2018 Mar 3;8(3):e020781. doi: 10.1136/bmjopen-2017-020781.

21.

Occult Sources of Bleeding in Blunt Trauma : A Narrative Review.

Yumoto T, Kosaki Y, Yamakawa Y, Iida A, Yamamoto H, Yamada T, Tsukahara K, Naito H, Osako T, Nakao A.

Acta Med Okayama. 2017 Oct;71(5):363-368. doi: 10.18926/AMO/55433. Review.

22.

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.

Osako T, Iwase T, Ushijima M, Yonekura R, Ohno S, Akiyama F.

Br J Cancer. 2017 Nov 7;117(10):1470-1477. doi: 10.1038/bjc.2017.311. Epub 2017 Sep 14.

23.

Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.

Shimoyama K, Osako T, Mitsuhashi T, Akiyama F, Iwase T.

Acta Med Okayama. 2017 Jun;71(3):233-240. doi: 10.18926/AMO/55206.

24.

Neck failure after elective neck dissection in patients with oral squamous cell carcinoma.

Shimamoto H, Oikawa Y, Osako T, Hirai H, Mochizuki Y, Tanaka K, Tomioka H, Harada H.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jul;124(1):32-36. doi: 10.1016/j.oooo.2017.03.003. Epub 2017 Mar 10.

PMID:
28483472
25.

Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.

Ogiya A, Yamazaki K, Horii R, Shien T, Horimoto Y, Masuda N, Inao T, Hosoda M, Ishida N, Osako T, Takahashi M, Endo Y, Miyoshi Y, Yasojima H, Tomioka N, Yamashita H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Breast Cancer. 2017 Jul;24(4):642. doi: 10.1007/s12282-017-0771-2. No abstract available.

PMID:
28378258
26.

CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.

Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O'Neil NJ, Santos ND, Silvester J, Wei V, Garcia J, Kabeer F, Lai D, Soriano P, Banáth J, Chiu DS, Yap D, Le DD, Ye FB, Zhang A, Thu K, Soong J, Lin SC, Tsai AH, Osako T, Algara T, Saunders DN, Wong J, Xian J, Bally MB, Brenton JD, Brown GW, Shah SP, Cescon D, Mak TW, Caldas C, Stirling PC, Hieter P, Balasubramanian S, Aparicio S.

Nat Commun. 2017 Feb 17;8:14432. doi: 10.1038/ncomms14432.

27.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Mori H, Kubo M, Yamaguchi R, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Oda Y, Nakamura M.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

28.

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.

Mori H, Kubo M, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Miyazaki T, Oda Y, Otsuka T, Nakamura M.

PLoS One. 2016 Dec 15;11(12):e0167016. doi: 10.1371/journal.pone.0167016. eCollection 2016.

29.

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.

Yamashita H, Ogiya A, Shien T, Horimoto Y, Masuda N, Inao T, Osako T, Takahashi M, Endo Y, Hosoda M, Ishida N, Horii R, Yamazaki K, Miyoshi Y, Yasojima H, Tomioka N; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Breast Cancer. 2016 Nov;23(6):830-843. Epub 2015 Oct 14.

30.

Case of 24-week Fetus Delivered from Mother on Life Support with Brain-death from Suicide Attempt: Ethical Issues Associated with Severe Complications.

Nishimura T, Kohama K, Osako T, Yamada T, Tanaka H, Nakao A, Kotani J.

Acta Med Okayama. 2016 Oct;70(5):389-392.

31.

Transplant Procurement Management Model Training: Marked Improvement in the Mindset of In-Hospital Procurement Coordinators at Hyogo Prefecture, Japan.

Yoshikawa M, Yoshinaga K, Imamura Y, Hayashi T, Osako T, Takahashi K, Kaneko M, Fujisawa M, Kamidono S.

Transplant Proc. 2016 Sep;48(7):2437-2441. doi: 10.1016/j.transproceed.2016.02.087.

PMID:
27742317
32.

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.

Ogiya A, Yamazaki K, Horii R, Shien T, Horimoto Y, Masuda N, Inao T, Hosoda M, Ishida N, Osako T, Takahashi M, Endo Y, Miyoshi Y, Yasojima H, Tomioka N, Yamashita H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Breast Cancer. 2017 May;24(3):473-482. doi: 10.1007/s12282-016-0730-3. Epub 2016 Sep 15. Erratum in: Breast Cancer. 2017 Jul;24(4):642.

33.

Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.

Miyoshi Y, Shien T, Ogiya A, Ishida N, Yamazaki K, Horii R, Horimoto Y, Masuda N, Yasojima H, Inao T, Osako T, Takahashi M, Tomioka N, Endo Y, Hosoda M, Doihara H, Miyoshi S, Yamashita H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Breast Cancer Res. 2016 Jul 2;18(1):73. doi: 10.1186/s13058-016-0731-3.

34.

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.

Enokido K, Watanabe C, Nakamura S, Ogiya A, Osako T, Akiyama F, Yoshimura A, Iwata H, Ohno S, Kojima Y, Tsugawa K, Motomura K, Hayashi N, Yamauchi H, Sato N.

Clin Breast Cancer. 2016 Aug;16(4):299-304. doi: 10.1016/j.clbc.2016.02.009. Epub 2016 Feb 11.

35.

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan.

Osako T, Nishimura R, Nishiyama Y, Fujisue M.

Mol Clin Oncol. 2015 Nov;3(6):1268-1274. Epub 2015 Sep 8.

36.

Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells.

Nguyen LV, Pellacani D, Lefort S, Kannan N, Osako T, Makarem M, Cox CL, Kennedy W, Beer P, Carles A, Moksa M, Bilenky M, Balani S, Babovic S, Sun I, Rosin M, Aparicio S, Hirst M, Eaves CJ.

Nature. 2015 Dec 10;528(7581):267-71. doi: 10.1038/nature15742. Epub 2015 Dec 2.

PMID:
26633636
37.

A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

Oncology. 2016;90(1):43-50. doi: 10.1159/000441525. Epub 2015 Nov 28.

PMID:
26613521
38.

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

J Clin Pathol. 2016 Mar;69(3):255-9. doi: 10.1136/jclinpath-2015-203174. Epub 2015 Sep 29.

39.

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.

Tashima R, Nishimura R, Osako T, Nishiyama Y, Okumura Y, Nakano M, Fujisue M, Toyozumi Y, Arima N.

PLoS One. 2015 Jul 15;10(7):e0119565. doi: 10.1371/journal.pone.0119565. eCollection 2015.

40.

Hemorrhagic shock due to ruptured left and right gastric artery aneurysm.

Nishimura T, Sakata H, Yamada T, Osako T, Kohama K, Kako Y, Achiwa S, Furukawa Y, Nakao A, Kotani J.

Acute Med Surg. 2015 May 12;3(1):39-42. doi: 10.1002/ams2.115. eCollection 2016 Jan.

41.

Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Osako T, Nishimura R, Nishiyama Y, Okumura Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Int J Clin Oncol. 2015 Dec;20(6):1093-101. doi: 10.1007/s10147-015-0827-2. Epub 2015 Apr 9.

PMID:
25855313
42.

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, Gelmon K, Chia S, Mar C, Wan A, Laks E, Biele J, Shumansky K, Rosner J, McPherson A, Nielsen C, Roth AJ, Lefebvre C, Bashashati A, de Souza C, Siu C, Aniba R, Brimhall J, Oloumi A, Osako T, Bruna A, Sandoval JL, Algara T, Greenwood W, Leung K, Cheng H, Xue H, Wang Y, Lin D, Mungall AJ, Moore R, Zhao Y, Lorette J, Nguyen L, Huntsman D, Eaves CJ, Hansen C, Marra MA, Caldas C, Shah SP, Aparicio S.

Nature. 2015 Feb 19;518(7539):422-6. doi: 10.1038/nature13952. Epub 2014 Nov 26.

43.

Enantioposition-selective copper-catalyzed azide-alkyne cycloaddition for construction of chiral biaryl derivatives.

Osako T, Uozumi Y.

Org Lett. 2014 Nov 21;16(22):5866-9. doi: 10.1021/ol502778j. Epub 2014 Oct 31.

PMID:
25360824
44.

Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.

Nishimura R, Osako T, Nishiyama Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Mol Clin Oncol. 2014 Nov;2(6):1062-1068. Epub 2014 Aug 22.

45.

Can carbon monoxide-poisoned victims be organ donors?

Fujisaki N, Nakao A, Osako T, Nishimura T, Yamada T, Kohama K, Sakata H, Ishikawa-Aoyama M, Kotani J.

Med Gas Res. 2014 Jul 31;4:13. doi: 10.1186/2045-9912-4-13. eCollection 2014. Review.

46.

Non-surgical pneumoperitoneum associated with mechanical ventilation.

Okamoto A, Nakao A, Matsuda K, Yamada T, Osako T, Sakata H, Yamaguchi Y, Terashima M, Iwano J, Kotani J.

Acute Med Surg. 2014 Jun 26;1(4):254-255. doi: 10.1002/ams2.52. eCollection 2014 Oct. No abstract available.

47.

Acute leukemia presenting as bone pain with normal white blood cell count.

Sakata H, Nakao A, Matsuda K, Yoshie N, Yamada T, Osako T, Iwano M, Kotani J.

Acute Med Surg. 2014 May 19;1(4):249. doi: 10.1002/ams2.46. eCollection 2014 Oct. No abstract available.

48.

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

Silwal-Pandit L, Vollan HK, Chin SF, Rueda OM, McKinney S, Osako T, Quigley DA, Kristensen VN, Aparicio S, Børresen-Dale AL, Caldas C, Langerød A.

Clin Cancer Res. 2014 Jul 1;20(13):3569-80. doi: 10.1158/1078-0432.CCR-13-2943. Epub 2014 May 6. Erratum in: Clin Cancer Res. 2015 Mar 15;21(6):1502.

49.

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.

Osako T, Iwase T, Ushijima M, Horii R, Fukami Y, Kimura K, Matsuura M, Akiyama F.

Cancer Sci. 2014 May;105(5):576-82. doi: 10.1111/cas.12381. Epub 2014 Mar 26.

50.

Clonal analysis via barcoding reveals diverse growth and differentiation of transplanted mouse and human mammary stem cells.

Nguyen LV, Makarem M, Carles A, Moksa M, Kannan N, Pandoh P, Eirew P, Osako T, Kardel M, Cheung AM, Kennedy W, Tse K, Zeng T, Zhao Y, Humphries RK, Aparicio S, Eaves CJ, Hirst M.

Cell Stem Cell. 2014 Feb 6;14(2):253-63. doi: 10.1016/j.stem.2013.12.011. Epub 2014 Jan 16.

Supplemental Content

Support Center